Though Christmas is right around the corner, the long biotech winter may soon be over. The Federal Reserve announced Wednesday it plans to cut interest
Two Bay Area venture capital firms that invest in biotech startups — but also put their money behind a broader swath of nascent companies in
Walls of redactions in the Federal Trade Commission complaint targeting Sanofi’s deal with Maze Therapeutics hold a vital question for the biopharma industry: Was there
Plus, news on Inductive Bio, AbelZeta Pharma, GPCR Therapeutics, Bridge Biotherapeutics and NextCure. Apellis preempts EU rejection for eye drug: The company expects a negative
Novo Nordisk will buy Alkermes’ tableting facility in Athlone, Ireland, for $92.5 million in cash to manufacture one of its blockbuster GLP-1 drugs — Rybelsus
Amgen is making a major addition to its research leadership, bringing former Novartis research executive Jay Bradner into a top role while shifting current R&D
Mild obstructive sleep apnea (OSA) was not easily distinguishable from primary snoring in children without polysomnography, analysis of randomized clinical trial data showed. The only
The Biden administration announced several actions Thursday aimed at lowering prescription drug costs, including decreasing some drug copays for Medicare beneficiaries and getting pricing concessions
Mpox vaccination with a two-shot, low-dose intradermal approach produced similar antibody titers levels compared with the standard subcutaneous dosing regimen, an observational study showed. Two
Among other solutions, educational campaigns along with expanding access to residential rehab programs to Medicare beneficiaries could mitigate the growing trend of drug overdose deaths